Standout Papers

Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adeno... 2021 2026 2022 2024190
  1. Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results (2021)
    Richard P. Baum, Christiane Schuchardt et al. Journal of Nuclear Medicine

Immediate Impact

1 by Nobel laureates 1 from Science/Nature 49 standout
Sub-graph 1 of 24

Citing Papers

The role and regulation of integrins in cell migration and invasion
2024 Standout
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
2 intermediate papers

Works of Frank Osterkamp being referenced

Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results
2021 Standout
Design and Synthesis of a New Class of Selective Integrin α5β1 Antagonists
2007

Author Peers

Author Last Decade Papers Cites
Frank Osterkamp 335 121 170 203 19 543
Jianyang Fang 344 101 95 187 33 462
Aurélie Prignon 199 65 242 134 25 621
Matthew J. Abrams 144 34 110 362 20 594
Peter Conti 144 14 173 220 18 513
Helen Callanan 239 84 224 34 16 530
Michela Aurilio 191 58 217 170 21 543
Rajesh Patel 174 40 298 27 18 594
Pamela Thompson 150 24 295 139 23 602
C R Divgi 302 48 204 243 11 572
Maciej P. Zerkowski 299 27 373 92 13 627

All Works

Loading papers...

Rankless by CCL
2026